nodes	percent_of_prediction	percent_of_DWPC	metapath
Estriol—SLCO1A2—Methotrexate—bone cancer	0.213	0.509	CbGbCtD
Estriol—ABCB1—Cisplatin—bone cancer	0.0887	0.212	CbGbCtD
Estriol—ABCB1—Doxorubicin—bone cancer	0.0594	0.142	CbGbCtD
Estriol—ABCB1—Methotrexate—bone cancer	0.0576	0.138	CbGbCtD
Estriol—ESR1—LKB1 signaling events—ETV4—bone cancer	0.0115	0.0522	CbGpPWpGaD
Estriol—ESR1—Signaling events mediated by HDAC Class II—BCOR—bone cancer	0.0113	0.0514	CbGpPWpGaD
Estriol—ESR2—Nuclear Receptors—NR1I2—bone cancer	0.00998	0.0455	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—FEV—bone cancer	0.00953	0.0434	CbGpPWpGaD
Estriol—Ethinyl Estradiol—NR1I2—bone cancer	0.00901	0.339	CrCbGaD
Estriol—ESR2—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00789	0.036	CbGpPWpGaD
Estriol—Venous thromboembolism—Epirubicin—bone cancer	0.00696	0.0207	CcSEcCtD
Estriol—Venous thromboembolism—Doxorubicin—bone cancer	0.00644	0.0192	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—GNA11—bone cancer	0.00605	0.0276	CbGpPWpGaD
Estriol—Estradiol—NR1I2—bone cancer	0.00595	0.224	CrCbGaD
Estriol—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00541	0.0247	CbGpPWpGaD
Estriol—ESR1—Signaling events mediated by HDAC Class II—TUBB2A—bone cancer	0.00533	0.0243	CbGpPWpGaD
Estriol—Dementia—Methotrexate—bone cancer	0.00532	0.0159	CcSEcCtD
Estriol—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00507	0.0231	CbGpPWpGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.00506	0.0231	CbGpPWpGaD
Estriol—ESR1—Nuclear Receptors—NR1I2—bone cancer	0.00503	0.0229	CbGpPWpGaD
Estriol—Infection—Carboplatin—bone cancer	0.00481	0.0143	CcSEcCtD
Estriol—Erythema nodosum—Epirubicin—bone cancer	0.00473	0.0141	CcSEcCtD
Estriol—Tenderness—Cisplatin—bone cancer	0.00456	0.0136	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—IGF1R—bone cancer	0.00442	0.0201	CbGpPWpGaD
Estriol—Erythema nodosum—Doxorubicin—bone cancer	0.00437	0.013	CcSEcCtD
Estriol—ESR2—Ovarian Infertility Genes—CDK4—bone cancer	0.00415	0.0189	CbGpPWpGaD
Estriol—Pain—Carboplatin—bone cancer	0.00414	0.0123	CcSEcCtD
Estriol—Embolism venous—Epirubicin—bone cancer	0.00405	0.0121	CcSEcCtD
Estriol—Vaginal moniliasis—Epirubicin—bone cancer	0.00405	0.0121	CcSEcCtD
Estriol—ESR2—Generic Transcription Pathway—ZNF77—bone cancer	0.00403	0.0184	CbGpPWpGaD
Estriol—ESR1—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00398	0.0181	CbGpPWpGaD
Estriol—Vulvovaginal candidiasis—Epirubicin—bone cancer	0.00389	0.0116	CcSEcCtD
Estriol—Fluid retention—Cisplatin—bone cancer	0.00378	0.0113	CcSEcCtD
Estriol—Embolism venous—Doxorubicin—bone cancer	0.00375	0.0112	CcSEcCtD
Estriol—Vaginal moniliasis—Doxorubicin—bone cancer	0.00375	0.0112	CcSEcCtD
Estriol—Vulvovaginal mycotic infection—Epirubicin—bone cancer	0.00374	0.0111	CcSEcCtD
Estriol—Vulvovaginal candidiasis—Doxorubicin—bone cancer	0.0036	0.0107	CcSEcCtD
Estriol—Polyp—Methotrexate—bone cancer	0.00359	0.0107	CcSEcCtD
Estriol—Deep vein thrombosis—Methotrexate—bone cancer	0.00359	0.0107	CcSEcCtD
Estriol—Vulvovaginal mycotic infection—Doxorubicin—bone cancer	0.00346	0.0103	CcSEcCtD
Estriol—Polyp—Epirubicin—bone cancer	0.00336	0.01	CcSEcCtD
Estriol—Cyst—Methotrexate—bone cancer	0.00327	0.00974	CcSEcCtD
Estriol—ESR1—Signaling mediated by p38-alpha and p38-beta—ATF1—bone cancer	0.00322	0.0147	CbGpPWpGaD
Estriol—Cardiac failure congestive—Cisplatin—bone cancer	0.00319	0.0095	CcSEcCtD
Estriol—Polyp—Doxorubicin—bone cancer	0.00311	0.00927	CcSEcCtD
Estriol—Cyst—Epirubicin—bone cancer	0.00306	0.00911	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—GNA11—bone cancer	0.00305	0.0139	CbGpPWpGaD
Estriol—Estramustine—CYP3A4—bone cancer	0.00304	0.114	CrCbGaD
Estriol—Seborrhoeic dermatitis—Epirubicin—bone cancer	0.003	0.00894	CcSEcCtD
Estriol—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00296	0.0135	CbGpPWpGaD
Estriol—Cerebrovascular accident—Cisplatin—bone cancer	0.00295	0.00879	CcSEcCtD
Estriol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00291	0.0133	CbGpPWpGaD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—MMP2—bone cancer	0.00284	0.0129	CbGpPWpGaD
Estriol—Cyst—Doxorubicin—bone cancer	0.00283	0.00843	CcSEcCtD
Estriol—Seborrhoeic dermatitis—Doxorubicin—bone cancer	0.00278	0.00827	CcSEcCtD
Estriol—ESR1—Estrogen Receptor Pathway—JUN—bone cancer	0.00277	0.0126	CbGpPWpGaD
Estriol—Vaginal haemorrhage—Epirubicin—bone cancer	0.00276	0.00823	CcSEcCtD
Estriol—ESR1—FOXM1 transcription factor network—CHEK2—bone cancer	0.00268	0.0122	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—WT1—bone cancer	0.00262	0.0119	CbGpPWpGaD
Estriol—Breast disorder—Cisplatin—bone cancer	0.00261	0.00778	CcSEcCtD
Estriol—Vaginal haemorrhage—Doxorubicin—bone cancer	0.00256	0.00762	CcSEcCtD
Estriol—Estropipate—CYP3A4—bone cancer	0.0025	0.094	CrCbGaD
Estriol—Bone disorder—Methotrexate—bone cancer	0.00242	0.00721	CcSEcCtD
Estriol—ESR1—Estrogen signaling pathway—BRAF—bone cancer	0.00241	0.011	CbGpPWpGaD
Estriol—Abdominal discomfort—Cisplatin—bone cancer	0.00239	0.00713	CcSEcCtD
Estriol—Breast pain—Epirubicin—bone cancer	0.00234	0.00698	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.00227	0.0104	CbGpPWpGaD
Estriol—ESR1—FOXM1 transcription factor network—BRCA2—bone cancer	0.00227	0.0103	CbGpPWpGaD
Estriol—Bone disorder—Epirubicin—bone cancer	0.00226	0.00674	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—bone cancer	0.00223	0.0102	CbGpPWpGaD
Estriol—Acute coronary syndrome—Cisplatin—bone cancer	0.0022	0.00654	CcSEcCtD
Estriol—Pulmonary embolism—Methotrexate—bone cancer	0.00218	0.00651	CcSEcCtD
Estriol—Vaginal inflammation—Methotrexate—bone cancer	0.00218	0.00651	CcSEcCtD
Estriol—Myocardial infarction—Cisplatin—bone cancer	0.00218	0.0065	CcSEcCtD
Estriol—Breast pain—Doxorubicin—bone cancer	0.00217	0.00646	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—MMP9—bone cancer	0.00213	0.00972	CbGpPWpGaD
Estriol—Hepatobiliary disease—Cisplatin—bone cancer	0.00211	0.00628	CcSEcCtD
Estriol—Bone disorder—Doxorubicin—bone cancer	0.00209	0.00624	CcSEcCtD
Estriol—Vaginal infection—Methotrexate—bone cancer	0.00206	0.00615	CcSEcCtD
Estriol—Pulmonary embolism—Epirubicin—bone cancer	0.00204	0.00609	CcSEcCtD
Estriol—Vaginal inflammation—Epirubicin—bone cancer	0.00204	0.00609	CcSEcCtD
Estriol—ESR1—Generic Transcription Pathway—ZNF77—bone cancer	0.00203	0.00925	CbGpPWpGaD
Estriol—Neoplasm—Methotrexate—bone cancer	0.00198	0.00589	CcSEcCtD
Estriol—Connective tissue disorder—Cisplatin—bone cancer	0.00196	0.00585	CcSEcCtD
Estriol—Fluid retention—Epirubicin—bone cancer	0.00194	0.00578	CcSEcCtD
Estriol—ESR2—Gene Expression—ZNF77—bone cancer	0.00194	0.00884	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00193	0.00881	CbGpPWpGaD
Estriol—Vaginal infection—Epirubicin—bone cancer	0.00193	0.00575	CcSEcCtD
Estriol—Visual impairment—Cisplatin—bone cancer	0.00193	0.00574	CcSEcCtD
Estriol—Pulmonary embolism—Doxorubicin—bone cancer	0.00189	0.00564	CcSEcCtD
Estriol—Vaginal inflammation—Doxorubicin—bone cancer	0.00189	0.00564	CcSEcCtD
Estriol—Cramps of lower extremities—Epirubicin—bone cancer	0.00188	0.0056	CcSEcCtD
Estriol—Eye disorder—Cisplatin—bone cancer	0.00187	0.00557	CcSEcCtD
Estriol—Cardiac disorder—Cisplatin—bone cancer	0.00186	0.00553	CcSEcCtD
Estriol—Neoplasm—Epirubicin—bone cancer	0.00185	0.00551	CcSEcCtD
Estriol—Thrombophlebitis—Methotrexate—bone cancer	0.00183	0.00546	CcSEcCtD
Estriol—Immune system disorder—Cisplatin—bone cancer	0.00181	0.00538	CcSEcCtD
Estriol—Fluid retention—Doxorubicin—bone cancer	0.0018	0.00535	CcSEcCtD
Estriol—Vaginal infection—Doxorubicin—bone cancer	0.00179	0.00532	CcSEcCtD
Estriol—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00179	0.00814	CbGpPWpGaD
Estriol—Ethinyl Estradiol—CYP3A4—bone cancer	0.00178	0.0672	CrCbGaD
Estriol—Abnormal vision—Epirubicin—bone cancer	0.00178	0.00531	CcSEcCtD
Estriol—Alopecia—Cisplatin—bone cancer	0.00177	0.00526	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.00176	0.00802	CbGpPWpGaD
Estriol—ESR1—Estrogen signaling pathway—JUN—bone cancer	0.00176	0.008	CbGpPWpGaD
Estriol—Malnutrition—Cisplatin—bone cancer	0.00174	0.00519	CcSEcCtD
Estriol—Cramps of lower extremities—Doxorubicin—bone cancer	0.00174	0.00518	CcSEcCtD
Estriol—Flatulence—Cisplatin—bone cancer	0.00171	0.00511	CcSEcCtD
Estriol—Thrombophlebitis—Epirubicin—bone cancer	0.00171	0.00511	CcSEcCtD
Estriol—Neoplasm—Doxorubicin—bone cancer	0.00171	0.0051	CcSEcCtD
Estriol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.0017	0.00775	CbGpPWpGaD
Estriol—ESR1—FOXM1 transcription factor network—CDK4—bone cancer	0.00168	0.00767	CbGpPWpGaD
Estriol—Visual disturbance—Methotrexate—bone cancer	0.00167	0.00499	CcSEcCtD
Estriol—Muscle spasms—Cisplatin—bone cancer	0.00167	0.00499	CcSEcCtD
Estriol—Vascular purpura—Epirubicin—bone cancer	0.00166	0.00494	CcSEcCtD
Estriol—Abnormal vision—Doxorubicin—bone cancer	0.00165	0.00492	CcSEcCtD
Estriol—Cardiac failure congestive—Epirubicin—bone cancer	0.00164	0.00488	CcSEcCtD
Estriol—Cerebrovascular accident—Methotrexate—bone cancer	0.00162	0.00482	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.0016	0.00731	CbGpPWpGaD
Estriol—Thrombophlebitis—Doxorubicin—bone cancer	0.00159	0.00473	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.00158	0.00721	CbGpPWpGaD
Estriol—Conjugated Estrogens—CYP3A4—bone cancer	0.00156	0.0587	CrCbGaD
Estriol—Estrone—CYP3A4—bone cancer	0.00155	0.0585	CrCbGaD
Estriol—ESR2—Validated nuclear estrogen receptor alpha network—JUN—bone cancer	0.00154	0.007	CbGpPWpGaD
Estriol—Vascular purpura—Doxorubicin—bone cancer	0.00153	0.00457	CcSEcCtD
Estriol—Cerebrovascular accident—Epirubicin—bone cancer	0.00151	0.00451	CcSEcCtD
Estriol—Cardiac failure congestive—Doxorubicin—bone cancer	0.00151	0.00451	CcSEcCtD
Estriol—Anxiety—Cisplatin—bone cancer	0.00148	0.0044	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00147	0.00438	CcSEcCtD
Estriol—ESR1—FOXM1 transcription factor network—RB1—bone cancer	0.00146	0.00667	CbGpPWpGaD
Estriol—Migraine—Epirubicin—bone cancer	0.00146	0.00435	CcSEcCtD
Estriol—Breast disorder—Methotrexate—bone cancer	0.00143	0.00427	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—MMP2—bone cancer	0.00143	0.00652	CbGpPWpGaD
Estriol—Anaphylactic shock—Cisplatin—bone cancer	0.00142	0.00423	CcSEcCtD
Estriol—Oedema—Cisplatin—bone cancer	0.00142	0.00423	CcSEcCtD
Estriol—Infection—Cisplatin—bone cancer	0.00141	0.0042	CcSEcCtD
Estriol—ESR1—FOXM1 transcription factor network—MMP2—bone cancer	0.0014	0.0064	CbGpPWpGaD
Estriol—Cerebrovascular accident—Doxorubicin—bone cancer	0.0014	0.00418	CcSEcCtD
Estriol—Nervous system disorder—Cisplatin—bone cancer	0.00139	0.00415	CcSEcCtD
Estriol—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—bone cancer	0.00139	0.00634	CbGpPWpGaD
Estriol—Skin disorder—Cisplatin—bone cancer	0.00138	0.00411	CcSEcCtD
Estriol—Asthma—Methotrexate—bone cancer	0.00137	0.00408	CcSEcCtD
Estriol—ESR2—Generic Transcription Pathway—NR1I2—bone cancer	0.00136	0.00621	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.00136	0.0062	CbGpPWpGaD
Estriol—ESR1—ATF-2 transcription factor network—PLAU—bone cancer	0.00136	0.00618	CbGpPWpGaD
Estriol—Migraine—Doxorubicin—bone cancer	0.00135	0.00403	CcSEcCtD
Estriol—Breast disorder—Epirubicin—bone cancer	0.00134	0.004	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.00134	0.00611	CbGpPWpGaD
Estriol—Abdominal discomfort—Methotrexate—bone cancer	0.00131	0.00392	CcSEcCtD
Estriol—Abdominal distension—Epirubicin—bone cancer	0.00129	0.00385	CcSEcCtD
Estriol—Asthma—Epirubicin—bone cancer	0.00128	0.00382	CcSEcCtD
Estriol—ESR1—ATF-2 transcription factor network—CDK4—bone cancer	0.00128	0.00585	CbGpPWpGaD
Estriol—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—bone cancer	0.00125	0.00572	CbGpPWpGaD
Estriol—Breast disorder—Doxorubicin—bone cancer	0.00124	0.0037	CcSEcCtD
Estriol—Gastrointestinal disorder—Cisplatin—bone cancer	0.00123	0.00365	CcSEcCtD
Estriol—Infestation—Methotrexate—bone cancer	0.00122	0.00364	CcSEcCtD
Estriol—Infestation NOS—Methotrexate—bone cancer	0.00122	0.00364	CcSEcCtD
Estriol—Depression—Methotrexate—bone cancer	0.00122	0.00363	CcSEcCtD
Estriol—Pain—Cisplatin—bone cancer	0.00121	0.00362	CcSEcCtD
Estriol—Abdominal distension—Doxorubicin—bone cancer	0.00119	0.00356	CcSEcCtD
Estriol—Asthma—Doxorubicin—bone cancer	0.00119	0.00354	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—PLAU—bone cancer	0.00118	0.00539	CbGpPWpGaD
Estriol—Estradiol—CYP3A4—bone cancer	0.00118	0.0443	CrCbGaD
Estriol—Weight increased—Epirubicin—bone cancer	0.00117	0.00348	CcSEcCtD
Estriol—Weight decreased—Epirubicin—bone cancer	0.00116	0.00346	CcSEcCtD
Estriol—Hepatobiliary disease—Methotrexate—bone cancer	0.00116	0.00344	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.00115	0.00523	CbGpPWpGaD
Estriol—Infestation NOS—Epirubicin—bone cancer	0.00114	0.00341	CcSEcCtD
Estriol—Infestation—Epirubicin—bone cancer	0.00114	0.00341	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.00112	0.0051	CbGpPWpGaD
Estriol—ESR1—ATF-2 transcription factor network—RB1—bone cancer	0.00111	0.00508	CbGpPWpGaD
Estriol—Hepatobiliary disease—Epirubicin—bone cancer	0.00108	0.00322	CcSEcCtD
Estriol—Weight increased—Doxorubicin—bone cancer	0.00108	0.00322	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—MMP9—bone cancer	0.00108	0.0049	CbGpPWpGaD
Estriol—Weight decreased—Doxorubicin—bone cancer	0.00107	0.0032	CcSEcCtD
Estriol—ESR1—ATF-2 transcription factor network—MMP2—bone cancer	0.00107	0.00488	CbGpPWpGaD
Estriol—Infestation NOS—Doxorubicin—bone cancer	0.00106	0.00315	CcSEcCtD
Estriol—Infestation—Doxorubicin—bone cancer	0.00106	0.00315	CcSEcCtD
Estriol—Visual impairment—Methotrexate—bone cancer	0.00106	0.00315	CcSEcCtD
Estriol—Hypersensitivity—Cisplatin—bone cancer	0.00105	0.00312	CcSEcCtD
Estriol—ESR1—FOXA1 transcription factor network—JUN—bone cancer	0.00104	0.00476	CbGpPWpGaD
Estriol—Erythema multiforme—Methotrexate—bone cancer	0.00104	0.00309	CcSEcCtD
Estriol—Eye disorder—Methotrexate—bone cancer	0.00103	0.00305	CcSEcCtD
Estriol—Cardiac disorder—Methotrexate—bone cancer	0.00102	0.00303	CcSEcCtD
Estriol—Oedema peripheral—Epirubicin—bone cancer	0.00101	0.00301	CcSEcCtD
Estriol—Connective tissue disorder—Epirubicin—bone cancer	0.00101	0.00301	CcSEcCtD
Estriol—Hepatobiliary disease—Doxorubicin—bone cancer	0.001	0.00298	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.001	0.00456	CbGpPWpGaD
Estriol—Angiopathy—Methotrexate—bone cancer	0.000995	0.00297	CcSEcCtD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.000995	0.00454	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000994	0.00453	CbGpPWpGaD
Estriol—Immune system disorder—Methotrexate—bone cancer	0.000991	0.00295	CcSEcCtD
Estriol—Visual impairment—Epirubicin—bone cancer	0.000989	0.00295	CcSEcCtD
Estriol—ESR1—Gene Expression—ZNF77—bone cancer	0.000977	0.00446	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000975	0.00444	CbGpPWpGaD
Estriol—Diarrhoea—Cisplatin—bone cancer	0.000972	0.0029	CcSEcCtD
Estriol—Erythema multiforme—Epirubicin—bone cancer	0.000971	0.00289	CcSEcCtD
Estriol—Alopecia—Methotrexate—bone cancer	0.000969	0.00289	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.000962	0.00439	CbGpPWpGaD
Estriol—Mental disorder—Methotrexate—bone cancer	0.000961	0.00286	CcSEcCtD
Estriol—Eye disorder—Epirubicin—bone cancer	0.000959	0.00286	CcSEcCtD
Estriol—Malnutrition—Methotrexate—bone cancer	0.000955	0.00285	CcSEcCtD
Estriol—Cardiac disorder—Epirubicin—bone cancer	0.000953	0.00284	CcSEcCtD
Estriol—ESR2—Gene Expression—FUS—bone cancer	0.000946	0.00431	CbGpPWpGaD
Estriol—Oedema peripheral—Doxorubicin—bone cancer	0.000936	0.00279	CcSEcCtD
Estriol—Connective tissue disorder—Doxorubicin—bone cancer	0.000933	0.00278	CcSEcCtD
Estriol—Angiopathy—Epirubicin—bone cancer	0.000931	0.00278	CcSEcCtD
Estriol—Immune system disorder—Epirubicin—bone cancer	0.000927	0.00276	CcSEcCtD
Estriol—Back pain—Methotrexate—bone cancer	0.000924	0.00275	CcSEcCtD
Estriol—Visual impairment—Doxorubicin—bone cancer	0.000915	0.00273	CcSEcCtD
Estriol—Alopecia—Epirubicin—bone cancer	0.000907	0.0027	CcSEcCtD
Estriol—Vomiting—Cisplatin—bone cancer	0.000903	0.00269	CcSEcCtD
Estriol—Mental disorder—Epirubicin—bone cancer	0.000899	0.00268	CcSEcCtD
Estriol—Erythema multiforme—Doxorubicin—bone cancer	0.000898	0.00268	CcSEcCtD
Estriol—Rash—Cisplatin—bone cancer	0.000896	0.00267	CcSEcCtD
Estriol—Dermatitis—Cisplatin—bone cancer	0.000895	0.00267	CcSEcCtD
Estriol—Malnutrition—Epirubicin—bone cancer	0.000894	0.00266	CcSEcCtD
Estriol—Eye disorder—Doxorubicin—bone cancer	0.000888	0.00265	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000887	0.00405	CbGpPWpGaD
Estriol—Cardiac disorder—Doxorubicin—bone cancer	0.000882	0.00263	CcSEcCtD
Estriol—Flatulence—Epirubicin—bone cancer	0.000881	0.00262	CcSEcCtD
Estriol—Tension—Epirubicin—bone cancer	0.000877	0.00261	CcSEcCtD
Estriol—Nervousness—Epirubicin—bone cancer	0.000868	0.00259	CcSEcCtD
Estriol—Back pain—Epirubicin—bone cancer	0.000864	0.00258	CcSEcCtD
Estriol—Angiopathy—Doxorubicin—bone cancer	0.000862	0.00257	CcSEcCtD
Estriol—Muscle spasms—Epirubicin—bone cancer	0.000859	0.00256	CcSEcCtD
Estriol—Immune system disorder—Doxorubicin—bone cancer	0.000858	0.00256	CcSEcCtD
Estriol—Nausea—Cisplatin—bone cancer	0.000844	0.00251	CcSEcCtD
Estriol—Alopecia—Doxorubicin—bone cancer	0.000839	0.0025	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.000834	0.0038	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000833	0.0038	CbGpPWpGaD
Estriol—Mental disorder—Doxorubicin—bone cancer	0.000832	0.00248	CcSEcCtD
Estriol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	0.000828	0.00378	CbGpPWpGaD
Estriol—Malnutrition—Doxorubicin—bone cancer	0.000827	0.00246	CcSEcCtD
Estriol—ESR1—ATF-2 transcription factor network—JUN—bone cancer	0.000826	0.00377	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.000815	0.00372	CbGpPWpGaD
Estriol—Flatulence—Doxorubicin—bone cancer	0.000815	0.00243	CcSEcCtD
Estriol—Tension—Doxorubicin—bone cancer	0.000811	0.00242	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000808	0.00368	CbGpPWpGaD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000807	0.00241	CcSEcCtD
Estriol—Nervousness—Doxorubicin—bone cancer	0.000803	0.00239	CcSEcCtD
Estriol—Back pain—Doxorubicin—bone cancer	0.0008	0.00238	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000797	0.00363	CbGpPWpGaD
Estriol—Muscle spasms—Doxorubicin—bone cancer	0.000795	0.00237	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000793	0.00361	CbGpPWpGaD
Estriol—Anaphylactic shock—Methotrexate—bone cancer	0.000779	0.00232	CcSEcCtD
Estriol—Infection—Methotrexate—bone cancer	0.000774	0.00231	CcSEcCtD
Estriol—ESR1—Validated nuclear estrogen receptor alpha network—JUN—bone cancer	0.000774	0.00353	CbGpPWpGaD
Estriol—Hypertension—Epirubicin—bone cancer	0.000772	0.0023	CcSEcCtD
Estriol—Nervous system disorder—Methotrexate—bone cancer	0.000764	0.00228	CcSEcCtD
Estriol—Anxiety—Epirubicin—bone cancer	0.000758	0.00226	CcSEcCtD
Estriol—Skin disorder—Methotrexate—bone cancer	0.000757	0.00226	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000756	0.00225	CcSEcCtD
Estriol—ESR2—SIDS Susceptibility Pathways—JUN—bone cancer	0.000753	0.00343	CbGpPWpGaD
Estriol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000741	0.00338	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—JUN—bone cancer	0.000738	0.00336	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000737	0.00336	CbGpPWpGaD
Estriol—Oedema—Epirubicin—bone cancer	0.000729	0.00217	CcSEcCtD
Estriol—Anaphylactic shock—Epirubicin—bone cancer	0.000729	0.00217	CcSEcCtD
Estriol—Infection—Epirubicin—bone cancer	0.000725	0.00216	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—JUN—bone cancer	0.000721	0.00329	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000719	0.00328	CbGpPWpGaD
Estriol—Shock—Epirubicin—bone cancer	0.000718	0.00214	CcSEcCtD
Estriol—Nervous system disorder—Epirubicin—bone cancer	0.000715	0.00213	CcSEcCtD
Estriol—Hypertension—Doxorubicin—bone cancer	0.000714	0.00213	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.00071	0.00324	CbGpPWpGaD
Estriol—Skin disorder—Epirubicin—bone cancer	0.000708	0.00211	CcSEcCtD
Estriol—Insomnia—Methotrexate—bone cancer	0.000705	0.0021	CcSEcCtD
Estriol—ESR1—LKB1 signaling events—TP53—bone cancer	0.000703	0.0032	CbGpPWpGaD
Estriol—Anxiety—Doxorubicin—bone cancer	0.000702	0.00209	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—MMP9—bone cancer	0.000701	0.0032	CbGpPWpGaD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000699	0.00208	CcSEcCtD
Estriol—ESR1—Generic Transcription Pathway—NR1I2—bone cancer	0.000687	0.00313	CbGpPWpGaD
Estriol—Dyspepsia—Methotrexate—bone cancer	0.000686	0.00204	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000676	0.00308	CbGpPWpGaD
Estriol—Oedema—Doxorubicin—bone cancer	0.000675	0.00201	CcSEcCtD
Estriol—Anaphylactic shock—Doxorubicin—bone cancer	0.000675	0.00201	CcSEcCtD
Estriol—Gastrointestinal disorder—Methotrexate—bone cancer	0.000673	0.00201	CcSEcCtD
Estriol—Infection—Doxorubicin—bone cancer	0.00067	0.002	CcSEcCtD
Estriol—Pain—Methotrexate—bone cancer	0.000666	0.00199	CcSEcCtD
Estriol—Shock—Doxorubicin—bone cancer	0.000664	0.00198	CcSEcCtD
Estriol—Nervous system disorder—Doxorubicin—bone cancer	0.000662	0.00197	CcSEcCtD
Estriol—Insomnia—Epirubicin—bone cancer	0.00066	0.00197	CcSEcCtD
Estriol—ESR2—Gene Expression—NR1I2—bone cancer	0.000656	0.00299	CbGpPWpGaD
Estriol—Skin disorder—Doxorubicin—bone cancer	0.000656	0.00195	CcSEcCtD
Estriol—SLCO1A2—Metabolism—NDUFA12—bone cancer	0.000651	0.00297	CbGpPWpGaD
Estriol—Dyspepsia—Epirubicin—bone cancer	0.000642	0.00191	CcSEcCtD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.000641	0.00292	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.00064	0.00292	CbGpPWpGaD
Estriol—Gastrointestinal pain—Methotrexate—bone cancer	0.000637	0.0019	CcSEcCtD
Estriol—Gastrointestinal disorder—Epirubicin—bone cancer	0.00063	0.00188	CcSEcCtD
Estriol—Pain—Epirubicin—bone cancer	0.000624	0.00186	CcSEcCtD
Estriol—Urticaria—Methotrexate—bone cancer	0.000619	0.00185	CcSEcCtD
Estriol—Abdominal pain—Methotrexate—bone cancer	0.000616	0.00184	CcSEcCtD
Estriol—Insomnia—Doxorubicin—bone cancer	0.00061	0.00182	CcSEcCtD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000606	0.00276	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.000605	0.00276	CbGpPWpGaD
Estriol—Gastrointestinal pain—Epirubicin—bone cancer	0.000596	0.00178	CcSEcCtD
Estriol—Dyspepsia—Doxorubicin—bone cancer	0.000594	0.00177	CcSEcCtD
Estriol—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000583	0.00174	CcSEcCtD
Estriol—ESR1—Regulation of Telomerase—EGFR—bone cancer	0.00058	0.00264	CbGpPWpGaD
Estriol—Urticaria—Epirubicin—bone cancer	0.000579	0.00173	CcSEcCtD
Estriol—Pain—Doxorubicin—bone cancer	0.000577	0.00172	CcSEcCtD
Estriol—Abdominal pain—Epirubicin—bone cancer	0.000577	0.00172	CcSEcCtD
Estriol—Hypersensitivity—Methotrexate—bone cancer	0.000574	0.00171	CcSEcCtD
Estriol—ESR1—Signaling by ERBB4—KIT—bone cancer	0.000566	0.00258	CbGpPWpGaD
Estriol—Gastrointestinal pain—Doxorubicin—bone cancer	0.000552	0.00164	CcSEcCtD
Estriol—Pruritus—Methotrexate—bone cancer	0.000551	0.00164	CcSEcCtD
Estriol—SLCO1A2—Metabolism—NT5C3A—bone cancer	0.000539	0.00246	CbGpPWpGaD
Estriol—Hypersensitivity—Epirubicin—bone cancer	0.000537	0.0016	CcSEcCtD
Estriol—Urticaria—Doxorubicin—bone cancer	0.000536	0.0016	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000535	0.00244	CbGpPWpGaD
Estriol—Abdominal pain—Doxorubicin—bone cancer	0.000534	0.00159	CcSEcCtD
Estriol—Diarrhoea—Methotrexate—bone cancer	0.000533	0.00159	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000526	0.0024	CbGpPWpGaD
Estriol—Pruritus—Epirubicin—bone cancer	0.000516	0.00154	CcSEcCtD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000516	0.00235	CbGpPWpGaD
Estriol—Dizziness—Methotrexate—bone cancer	0.000515	0.00154	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000503	0.00229	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000501	0.00228	CbGpPWpGaD
Estriol—Diarrhoea—Epirubicin—bone cancer	0.000499	0.00149	CcSEcCtD
Estriol—Hypersensitivity—Doxorubicin—bone cancer	0.000497	0.00148	CcSEcCtD
Estriol—Vomiting—Methotrexate—bone cancer	0.000496	0.00148	CcSEcCtD
Estriol—Rash—Methotrexate—bone cancer	0.000491	0.00146	CcSEcCtD
Estriol—Dermatitis—Methotrexate—bone cancer	0.000491	0.00146	CcSEcCtD
Estriol—Headache—Methotrexate—bone cancer	0.000488	0.00145	CcSEcCtD
Estriol—ESR2—Gene Expression—EIF2S1—bone cancer	0.000485	0.00221	CbGpPWpGaD
Estriol—Dizziness—Epirubicin—bone cancer	0.000482	0.00144	CcSEcCtD
Estriol—Pruritus—Doxorubicin—bone cancer	0.000477	0.00142	CcSEcCtD
Estriol—ESR1—Gene Expression—FUS—bone cancer	0.000477	0.00218	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—TP53—bone cancer	0.000476	0.00217	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.00047	0.00214	CbGpPWpGaD
Estriol—Vomiting—Epirubicin—bone cancer	0.000464	0.00138	CcSEcCtD
Estriol—Nausea—Methotrexate—bone cancer	0.000463	0.00138	CcSEcCtD
Estriol—Diarrhoea—Doxorubicin—bone cancer	0.000462	0.00138	CcSEcCtD
Estriol—Rash—Epirubicin—bone cancer	0.00046	0.00137	CcSEcCtD
Estriol—Dermatitis—Epirubicin—bone cancer	0.000459	0.00137	CcSEcCtD
Estriol—Headache—Epirubicin—bone cancer	0.000457	0.00136	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.000448	0.00204	CbGpPWpGaD
Estriol—Dizziness—Doxorubicin—bone cancer	0.000446	0.00133	CcSEcCtD
Estriol—ESR1—Signaling by ERBB4—MDM2—bone cancer	0.000446	0.00203	CbGpPWpGaD
Estriol—Nausea—Epirubicin—bone cancer	0.000433	0.00129	CcSEcCtD
Estriol—Vomiting—Doxorubicin—bone cancer	0.000429	0.00128	CcSEcCtD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000428	0.00195	CbGpPWpGaD
Estriol—Rash—Doxorubicin—bone cancer	0.000426	0.00127	CcSEcCtD
Estriol—Dermatitis—Doxorubicin—bone cancer	0.000425	0.00127	CcSEcCtD
Estriol—Headache—Doxorubicin—bone cancer	0.000423	0.00126	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000423	0.00193	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000422	0.00192	CbGpPWpGaD
Estriol—ESR2—Gene Expression—EZH2—bone cancer	0.000421	0.00192	CbGpPWpGaD
Estriol—Nausea—Doxorubicin—bone cancer	0.000401	0.00119	CcSEcCtD
Estriol—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	0.0004	0.00182	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—JUN—bone cancer	0.00039	0.00178	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000371	0.00169	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000358	0.00163	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000357	0.00163	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000356	0.00163	CbGpPWpGaD
Estriol—ESR1—Gene Expression—NR1I2—bone cancer	0.000331	0.00151	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000323	0.00147	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000308	0.0014	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—EGFR—bone cancer	0.000306	0.0014	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—EGFR—bone cancer	0.000305	0.00139	CbGpPWpGaD
Estriol—ABCB1—Metabolism—NDUFA12—bone cancer	0.000279	0.00127	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000265	0.00121	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—TP53—bone cancer	0.000257	0.00117	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000254	0.00116	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—RGS1—bone cancer	0.000248	0.00113	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—GRM4—bone cancer	0.000248	0.00113	CbGpPWpGaD
Estriol—ESR1—Gene Expression—EIF2S1—bone cancer	0.000244	0.00111	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—ENO2—bone cancer	0.000236	0.00108	CbGpPWpGaD
Estriol—ABCB1—Metabolism—NT5C3A—bone cancer	0.000231	0.00105	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—DHFR—bone cancer	0.000219	0.000999	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—GRM1—bone cancer	0.000215	0.000981	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000213	0.000972	CbGpPWpGaD
Estriol—ESR1—Gene Expression—EZH2—bone cancer	0.000212	0.000968	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—GNA11—bone cancer	0.000205	0.000934	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000197	0.000896	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000189	0.000864	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—CYP3A4—bone cancer	0.000186	0.000847	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000185	0.000842	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000171	0.000779	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—GSTP1—bone cancer	0.000159	0.000724	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—SMO—bone cancer	0.000152	0.000691	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—GNA11—bone cancer	0.000139	0.000632	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000134	0.000612	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—ATF1—bone cancer	0.000129	0.000587	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—IL3—bone cancer	0.000126	0.000573	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000113	0.000514	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TGFBR2—bone cancer	0.000107	0.00049	CbGpPWpGaD
Estriol—ABCB1—Metabolism—ENO2—bone cancer	0.000101	0.000461	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—IGF1R—bone cancer	0.000101	0.000461	CbGpPWpGaD
Estriol—ABCB1—Metabolism—DHFR—bone cancer	9.38e-05	0.000428	CbGpPWpGaD
Estriol—ABCB1—Metabolism—GNA11—bone cancer	8.77e-05	0.0004	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PTGS2—bone cancer	8.23e-05	0.000375	CbGpPWpGaD
Estriol—ABCB1—Metabolism—CYP3A4—bone cancer	7.95e-05	0.000362	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—KIT—bone cancer	7.33e-05	0.000334	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—BRAF—bone cancer	6.89e-05	0.000314	CbGpPWpGaD
Estriol—ABCB1—Metabolism—GSTP1—bone cancer	6.8e-05	0.00031	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—MDM2—bone cancer	5.78e-05	0.000263	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—JUN—bone cancer	5.02e-05	0.000229	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—MMP9—bone cancer	4.88e-05	0.000223	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—EGFR—bone cancer	3.95e-05	0.00018	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PTGS2—bone cancer	3.52e-05	0.000161	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TP53—bone cancer	3.31e-05	0.000151	CbGpPWpGaD
